IL6 and inflammatory bowel disease: Interleukin‐6 (IL‐6) is a keystone cytokine that has pro‐inflammatory properties in the progression of IBD (Hunter and Jones 2015) and we observed that the serum IL‐6 level in the DSS + IF group was significantly decreased when compared to the DSS group (Figure 4C).